Iron Deficiency in Runners: Ferritin, Fatigue & the Complete Protocol

Iron is the mineral backbone of aerobic performance. Approximately 70% of the body's iron is bound within hemoglobin — the oxygen-carrying protein in red blood cells that transports O2 from lungs to working muscles. Another 10% sits in myoglobin, the intramuscular oxygen reservoir that supplies mitochondria during contractile work. The remaining fraction, often dismissed as 'storage,' actually does something critical: it builds the iron-sulfur clusters and heme groups of the mitochondrial electron transport chain enzymes — cytochromes a, b, and c, plus aconitase in the Krebs cycle. These enzymes generate ATP aerobically. When iron runs short, all three compartments suffer, and the result is the classic runner's fatigue pattern: elevated heart rate at easy paces, reduced time-to-exhaustion, and a sense that every run is harder than it should be.

Peeling et al. (2008, 2014) formalized a three-stage classification that remains the clinical standard for athletes. Stage 1 is iron depletion: serum ferritin falls below 35 ng/mL while hemoglobin and transferrin saturation remain normal. The athlete may feel fine, but storage iron is being exhausted. Stage 2 is iron-deficient non-anemic (IDNA): ferritin drops further, transferrin saturation falls below 16%, and tissue iron enzymes begin to fail — yet hemoglobin is still within the reference range. This is the most clinically deceptive stage, because a standard CBC reassures the runner that they are 'fine' while VO2 max, time-to-exhaustion, and submaximal economy are all significantly impaired. Stage 3 is frank iron-deficiency anemia, with hemoglobin below 12 g/dL in women or 13 g/dL in men.

The performance cost of IDNA — without anemia — is remarkable. Brutsaert et al. (2003) gave iron-depleted women with normal hemoglobin a 6-week supplementation protocol and measured a significant improvement in maximal oxygen uptake and endurance capacity compared to placebo. DellaValle & Haas (2014) found that iron-depleted collegiate rowers showed impaired 4K ergometer time trials that resolved with iron repletion. Pasricha et al. (2014), in a meta-analysis of non-anemic iron-deficient women, found that supplementation produced measurable improvements in maximal and submaximal exercise performance. The takeaway is unambiguous: waiting for hemoglobin to drop before treating iron depletion is sports-medicine malpractice.

For runners specifically, iron's role extends beyond oxygen transport to recovery capacity. Iron-dependent enzymes are required for collagen synthesis, neurotransmitter production (particularly dopamine), and thyroid hormone conversion (T4 to T3) — all systems that modulate training response. Low iron can also depress ventilatory efficiency through effects on peripheral chemoreceptors. This is why iron-depleted runners often describe a distinctive symptom cluster: legs that feel heavy from the first step, unusual breathlessness, inability to access higher gears during intervals, and an inexplicably elevated resting heart rate. The body has lost its capacity to extract and deliver oxygen efficiently, and every system that depends on aerobic metabolism pays the price.

Serum ferritin is the single most useful biomarker for runners because it reflects the body's iron storage pool — the reserve that gets depleted before hemoglobin begins to drop. The WHO defines iron deficiency at ferritin <15 ng/mL in adults, but this threshold was derived from sedentary populations and defines the point at which anemia becomes likely, not the point at which performance begins to suffer. Sports medicine has progressively moved its treatment thresholds upward. Current consensus (Sim et al. 2019, Clénin et al. 2015) considers ferritin <30 ng/mL clearly symptomatic for endurance athletes, <50 ng/mL suboptimal for high-volume training, and recommends maintaining ferritin >50 ng/mL (ideally 50–100 ng/mL) during heavy training blocks.

The critical complication is that ferritin behaves as an acute-phase reactant. During systemic inflammation — whether from infection, injury, or a recent hard training session — ferritin rises artificially, masking true iron depletion. A runner who completes a marathon or a demanding interval session can have ferritin elevated 30–50% above baseline for 24–72 hours. If the blood draw is timed poorly, a reading of 45 ng/mL might represent a true baseline of 25 ng/mL. This is why every iron panel should include a C-reactive protein (CRP) measurement. If CRP is elevated (>5 mg/L), the ferritin value is unreliable and the test should be repeated after a rest period. Soluble transferrin receptor (sTfR) is unaffected by inflammation and serves as a complementary marker in ambiguous cases.

Transferrin saturation (TSAT) provides a window into iron in transit. Normal values are 20–50%. Below 20% indicates that the plasma iron supply to tissues is inadequate even if storage ferritin looks acceptable; above 50% may suggest iron overload or hemochromatosis. In the early stages of iron depletion, ferritin falls first, followed by TSAT, and only then does hemoglobin begin to drop. The sequence is why a single hemoglobin value cannot detect early-stage deficiency. For athletes, an ideal iron panel includes ferritin, CRP, TSAT, and a complete blood count — together they paint a complete picture that no single number can provide.

The practical ferritin framework for runners is best summarized in a table of functional ranges. Values should always be interpreted alongside symptoms, training demands, and inflammatory markers — a ferritin of 40 ng/mL in a rest-week easy runner is very different from 40 ng/mL in a runner peaking for a marathon. The goal is not chasing a specific number but maintaining functional capacity during the training block that matters most.

Ferritin Ranges & Expected Performance Status

Foot-strike hemolysis is a phenomenon unique to runners, first characterized in the 1960s and rigorously documented by Telford et al. (2003). With every stride, the red blood cells traveling through capillaries in the plantar surface of the foot are subjected to compressive and shear forces as the foot strikes the ground. A fraction of these cells — particularly older, more fragile ones — rupture mechanically, releasing free hemoglobin into plasma. Telford's group measured significant decreases in plasma haptoglobin (which binds free hemoglobin) and increases in plasma free hemoglobin after just 60 minutes of running on a hard surface. The effect scaled with impact: treadmill running at equivalent intensity produced less hemolysis than road running, and heavier runners with stiffer foot strikes showed greater effects. Peeling et al. (2008) extended this work, demonstrating that intense interval sessions produced the largest acute hemolytic responses.

The real iron cost of foot-strike hemolysis is modest in absolute terms — probably 1–3 mL of red cell mass per hard session — but it matters because the hemoglobin iron released must be recycled, scavenged, or excreted. More importantly, foot-strike hemolysis is only one part of a broader iron-loss profile unique to running. Sweat losses contribute approximately 0.3–0.5 mg iron per liter of sweat, meaning a runner who sweats 2 L during a long run can lose close to 1 mg via sweat alone. Gastrointestinal microbleeds during hard efforts — documented in up to 20% of endurance athletes after marathon distances (Rudzki et al. 1995) — add further losses. Menstruating women add 15–25 mg per cycle on top of this. The total can easily exceed the 1–2 mg/day that heme and non-heme iron absorption typically provides.

Hepcidin is the master regulator that makes this problem far worse. Produced by the liver, hepcidin binds ferroportin — the iron transporter on enterocytes and macrophages — and triggers its degradation, effectively shutting off intestinal iron absorption. Peeling et al. (2017), in a landmark series of studies, demonstrated that serum hepcidin rises 2–4 hours after hard exercise and remains elevated for 3–6 hours, driven by the IL-6 inflammatory response to training stress. This means that any iron ingested — from food or supplements — during the 3–6 hour post-training window is absorbed at substantially reduced efficiency. For a high-mileage runner who trains most days of the week, there may be very little time when iron absorption is actually optimal.

The practical implications for high-mileage runners are substantial. First, iron supplementation is best timed away from training, ideally on rest-day mornings or at least 3–6 hours before or after hard sessions. Second, consuming iron-rich foods with hard-session recovery meals is less effective than eating them earlier in the day on training days, or on rest days. Third, the runners most vulnerable to this compounded effect are those running >80 km/week — particularly those doing multiple high-intensity sessions per week — because every hard effort renews the hepcidin blockade. This is why elite distance runners, despite eating carefully, frequently show chronic iron depletion. The physiology of running itself works against iron status in a way that simply doesn't happen in lower-impact, lower-intensity activities.

The insidious thing about iron deficiency in runners is that it does not announce itself with obvious symptoms. Instead, it arrives as a gradual erosion of training capacity that many runners attribute to overtraining, age, or inadequate recovery. The earliest signal is typically a disconnect between perceived effort and objective output: a run that felt 8/10 RPE delivered a pace that would have been 6/10 a month earlier. Easy runs start to feel like tempo runs. Interval paces that were automatic become struggle. Heart rate at a given easy pace may creep up 5–10 beats per minute above baseline — a phenomenon known as 'cardiac drift at submaximal intensity' that is highly suspicious for iron depletion in an otherwise well-recovered athlete.

DellaValle (2014) found that collegiate rowers with IDNA showed measurably elevated submaximal heart rate, decreased time-to-exhaustion, and reduced gross efficiency — all before hemoglobin had dropped. Pasricha et al. (2014) meta-analyzed 24 trials and concluded that iron-depleted non-anemic women consistently showed a 5–10% performance decrement that fully resolved with supplementation. For a runner, this translates to the difference between hitting your splits and wondering why your legs feel leaden from the first kilometer. If you are meticulous about training, sleep, and nutrition, and your performance is still regressing — iron should be the first suspect.

Non-exercise symptoms are also highly suggestive when they cluster. Unusual cold hands and feet (peripheral vasoconstriction from reduced oxygen delivery), brittle fingernails that split at the edges, spoon-shaped nails (koilonychia, a late sign), hair thinning or increased shedding, pale conjunctiva (visible by pulling down the lower eyelid), restless legs at night (iron is required for dopamine synthesis), and pica — unusual cravings for non-food substances, particularly ice (pagophagia), raw starch, or clay. Pagophagia in particular is almost pathognomonic for iron deficiency and often resolves within days of supplementation. Any runner who finds themselves compulsively chewing ice through the day should test their ferritin.

Psychological and cognitive symptoms are underappreciated. Iron deficiency affects dopamine and norepinephrine synthesis and is associated with lowered exercise motivation, blunted mood, difficulty with complex cognitive tasks, and an overall sense of grayness that runners often describe as 'training burnout.' Pasricha et al. (2014) demonstrated that iron supplementation improved mood and fatigue scores in non-anemic iron-deficient women independently of any hemoglobin change. The practical rule for runners: if your training is regressing, your mood is flatter than usual, and your easy runs have started to feel surprisingly hard — before you overhaul your training, before you assume you are overtrained, and before you take an unplanned rest week — get a full iron panel drawn.

The most common reason runners remain iron-deficient despite seeing a doctor is that the wrong tests are ordered. A standard 'blood test' or 'basic metabolic panel' does not include any iron markers. Even a complete blood count (CBC) detects only Stage 3 anemia — it will entirely miss the early-to-mid-stage depletion that is quietly derailing performance. The correct request is specific: a ferritin level, a complete blood count (CBC) with indices (hemoglobin, hematocrit, MCV, MCH, RDW), transferrin saturation (TSAT, which requires serum iron and TIBC), and a C-reactive protein (CRP) to assess inflammation. Collectively, this is often called an 'iron studies' panel. If you are assertive about requesting all four, you will get a complete picture; if you accept whatever the doctor orders by default, you will typically get only a CBC.

Timing matters. Because hepcidin and ferritin both rise with acute inflammation from training, blood should be drawn at least 72 hours after the last hard session, ideally first thing in the morning, fasted, and after a rest day. Drawing blood the day after a long run or interval session can falsely elevate ferritin and falsely depress serum iron, leading to misleading results. For runners who supplement, testing should be done before the morning supplement dose. Re-testing intervals depend on status: a runner starting supplementation should re-test at 8 weeks to confirm ferritin is rising, then every 3 months until the target range is reached, then every 6 months for maintenance. Non-supplementing athletes with healthy baseline values can test annually.

Interpretation of the panel requires reading the markers together rather than in isolation. If ferritin is low and CRP is also elevated, the ferritin reading understates the deficiency — the 'true' value is even lower. If ferritin is borderline (30–50 ng/mL) but TSAT is below 20%, functional iron deficiency is likely. If ferritin and TSAT are both normal but MCV (mean corpuscular volume) is declining year-over-year, early functional change is occurring. Red cell distribution width (RDW) rising above 14.5% is another early warning sign, reflecting a mixed population of red cells as iron supply becomes intermittent.

The table below summarizes how to read an iron panel the way a sports medicine physician would. Note the distinction between 'normal range' (the lab reference range, derived from sedentary adults) and 'runner optimal' (the target for an endurance athlete). This distinction is where most primary care physicians — who are not trained in sports medicine — miss the diagnosis in athletes.

Iron Panel Interpretation for Runners

Dietary iron exists in two chemical forms with dramatically different bioavailabilities. Heme iron — bound within the porphyrin ring of hemoglobin and myoglobin in animal tissues — is absorbed at 15–35% efficiency and is largely unaffected by other dietary factors. Non-heme iron, which predominates in plant foods and fortified cereals, is absorbed at just 2–20% efficiency and is exquisitely sensitive to enhancers and inhibitors in the same meal (Hurrell & Egli 2010). A 100-gram serving of beef delivers approximately 2.7 mg of iron, of which roughly 0.7 mg is actually absorbed. A 100-gram serving of lentils delivers roughly 3.3 mg of iron, but only 0.2–0.5 mg is absorbed without optimization. For runners, understanding this distinction is the difference between meeting iron needs and chronic deficiency.

The highest-yield heme iron sources, per serving, are: beef liver (6.5 mg per 100 g, ~30% absorbed), oysters (5.1 mg per 100 g), beef sirloin (2.7 mg per 100 g), dark chicken meat (1.3 mg per 100 g), and sardines (2.9 mg per 100 g). Red meat 2–3 times per week is the single most effective dietary intervention for iron status in omnivorous runners. For plant-forward eaters, the highest non-heme sources are: lentils (3.3 mg per 100 g cooked), pumpkin seeds (8.8 mg per 30 g — among the densest plant sources), spinach (2.7 mg per 100 g cooked), fortified breakfast cereals (typically 4–18 mg per serving), tofu (1.8 mg per 100 g), and kidney beans (2.2 mg per 100 g cooked).

Absorption optimization is where most runners can make the biggest practical gains without changing what they eat. Vitamin C at 50–100 mg taken with a non-heme iron source approximately doubles absorption by reducing ferric (Fe3+) iron to the more absorbable ferrous (Fe2+) form and chelating it into a soluble complex. Squeezing lemon over lentils, pairing beans with bell peppers, or having fortified cereal with strawberries or orange juice produces a measurable absorption boost. Inhibitors work in the opposite direction: the tannins in tea and coffee reduce non-heme iron absorption by 50–70% when consumed in the same meal (Morck et al. 1983), calcium competes directly with iron for transporters (reducing absorption by 40% at doses of 300+ mg), and phytates in whole grains, nuts, and legumes bind iron in the gut. The practical rule: separate coffee, tea, dairy, and calcium supplements from iron-rich meals by at least 1–2 hours.

A runner-friendly high-iron day might look like: breakfast of fortified oatmeal with pumpkin seeds and strawberries (iron + vitamin C, no coffee yet); coffee 90 minutes later; lunch of lentil soup with a side of sautéed spinach squeezed with lemon; an afternoon snack of hummus with red bell pepper strips; and dinner of beef stir-fry with broccoli. Total iron content approaches 25–30 mg with high absorption thanks to repeated vitamin C pairing and tea/coffee timing. For vegetarian and especially vegan runners — whose average dietary iron intake is often higher than omnivores but whose absorption efficiency is roughly 1.8× lower — meeting needs through food alone is possible but requires this kind of deliberate structure. When in doubt, adding a modest supplement on rest days is often easier than perfecting daily meal timing.

The traditional iron supplementation protocol — 60–200 mg of elemental iron divided into two or three daily doses — was standard medical practice for decades. It was also wrong for most athletes. The foundational work of Moretti et al. (2015) and Stoffel et al. (2017, 2020) fundamentally reshaped our understanding of how to dose iron orally. Using stable iron isotopes to directly measure absorption, this Swiss research group demonstrated that a single 60–120 mg oral iron dose spikes serum hepcidin for approximately 24 hours. Hepcidin, the master iron-regulator, shuts down enterocyte iron uptake when it rises. This means that the second dose taken the same day, or the first dose taken the following morning, is absorbed at dramatically reduced efficiency — often less than 20% of the first dose.

The solution is counterintuitive but now well-validated: take iron every other day instead of every day, and take the daily dose as a single morning administration rather than split. Stoffel et al. (2020) showed that alternate-day dosing produced roughly 40–50% greater total iron absorption over a 14-day treatment period compared to daily dosing — with substantially less GI distress (nausea, constipation, dark stools) because the gut is exposed to iron on fewer days. For most iron-deficient female runners, a protocol of 80–100 mg ferrous sulfate (or equivalent elemental iron from another salt), taken every other day, first thing in the morning, on an empty stomach with a glass of orange juice or a 250 mg vitamin C tablet, produces excellent ferritin recovery over 2–3 months.

Not all iron supplements are equal. Ferrous sulfate is the cheapest and most widely studied but has the highest rate of GI side effects. Ferrous bisglycinate (iron chelated to two glycine molecules) is absorbed better at lower doses and is substantially better tolerated — Milman et al. (2014) showed equivalent efficacy to ferrous sulfate at half the dose. Heme iron polypeptide, derived from animal hemoglobin, is expensive but extremely well tolerated and does not trigger hepcidin as strongly. Liquid iron preparations (ferrous gluconate, iron sucrose) are useful for runners with severe GI sensitivity. Liposomal iron is marketed heavily but has limited independent evidence. For runners who cannot tolerate oral iron — or who have malabsorption — IV iron (ferric carboxymaltose or iron sucrose) administered under medical supervision restores ferritin dramatically within 2–4 weeks and is now commonly used in elite sports medicine.

Timing of iron supplementation around training is critical given the hepcidin dynamics of exercise (Sim et al. 2019). Iron should be taken at least 3–6 hours before or after a hard training session, ideally on rest-day mornings or the morning of an easy day. Never take iron within 3 hours after a long run or intervals — hepcidin is still elevated, and absorption is minimal. Additionally, always separate iron from dairy, calcium supplements, coffee, and tea by at least 2 hours. The most common reasons supplementation fails are: taking it with breakfast alongside coffee and milk, taking it in divided doses daily, and giving up after 4–6 weeks because GI symptoms developed from over-aggressive dosing. The alternate-day protocol solves all three problems simultaneously.

Iron Supplement Comparison

Iron deficiency is not evenly distributed across the running population. Identifying which runners carry the highest risk allows for proactive testing before performance suffers. Menstruating women are the single largest at-risk group — monthly blood loss averages 30–40 mL, translating to 15–25 mg of iron lost per cycle, on top of the sweat, GI, and foot-strike losses shared by all runners. Roughly 30–50% of female distance runners have ferritin <30 ng/mL on routine screening, and the prevalence approaches 60% in adolescent female runners (Koehler et al. 2012, Parks et al. 2017). Women with heavy menstrual bleeding (>80 mL/cycle), short cycles (<24 days), or those using copper IUDs are at dramatically elevated risk and should test every 6 months regardless of symptoms.

Vegetarian and vegan runners are the second major at-risk cohort. Although plant-based diets typically contain adequate total iron on paper, the absorption efficiency is roughly 1.8× lower than omnivorous diets due to the absence of heme iron and the abundance of phytates (Hunt 2003). Female vegan runners combining menstrual losses with non-heme-only intake show iron deficiency rates approaching 60% in some cohorts. Strategic food pairing — vitamin C with every iron-containing meal, separation from coffee/tea/calcium, soaking or sprouting legumes to reduce phytates — helps but often does not fully close the gap. Most serious plant-based endurance athletes benefit from annual testing and, frequently, intermittent supplementation.

Surprisingly, elite male runners are also disproportionately affected. Koehler et al. (2012) studied 193 elite male endurance athletes across multiple disciplines and found that 17% had ferritin below 35 ng/mL — far higher than the 3–5% expected in sedentary men. The drivers are the same mechanisms that affect women: foot-strike hemolysis, GI microbleeds, sweat losses, and hepcidin elevation from frequent hard training. Elite and high-mileage male runners (>100 km/week), particularly those with frequent interval sessions, should test annually even without symptoms. Adolescent runners of both sexes — whose iron demands are elevated by rapid growth on top of training — are another high-risk group, as are runners recently returned from altitude training (where EPO-driven erythropoiesis transiently depletes iron stores) and postpartum runners (whose iron stores are often dramatically depleted by pregnancy and delivery).

The practical decision framework for deciding whether to test is straightforward and should be followed by any serious runner: (1) If you are a menstruating female runner, test baseline ferritin and re-test every 6–12 months regardless of symptoms. (2) If you are vegan or vegetarian, test baseline and re-test annually. (3) If you run more than 80 km/week or do 3+ high-intensity sessions per week, test annually. (4) If you have just returned from altitude camp, completed pregnancy, or gone through a major growth spurt, test within 2–3 months. (5) If any of the symptoms described earlier — unexplained fatigue, elevated easy-pace heart rate, workout regression, pica, cold extremities — emerge, test immediately. (6) If you are supplementing, test 8 weeks after starting, then every 3 months until stable, then every 6 months. This framework catches the vast majority of deficiencies early enough to intervene before performance collapses — and is the single most useful health practice a runner can adopt.